The current research has centered on the use of pharmacological and binding affinity methods to test the 36 compounds as bioactive constituents’ inhibitors for COVID-19. Six compounds out of 36 phytoconstituents (rutin, quercetin, catechin gallate, rhamnetin, campesterol and stigmasterol) have demonstrated outstanding molecular docking and drug-like properties as HIV inhibitors Lopinavir and Indinavir. Interestingly, the lowest binding energies (LBE) and the inhibition constant ( K i ) have showed that these compounds are able to bind to the P-glycoprotein substrate of 3CL pro and Nsp15. Interestingly, rutin has been found to be an excellent potential inhibitor for COVID-19 proteins because it has the best LBE score and K i value than those of other compounds, and of its ability to form strong H-bonds with COVID-19 proteins. The compounds that come next to the rutin compound are stigmasterol and campesterol. As a result, these compounds are considered possible novel inhibitors of COVID-19. In order to validate the computational results, more in vitro and in vivo investigations are required to support the findings of this research.
Chlorinated benzoic acids (CBA) have been intentionally released to the environment due to their use in agriculture as herbicides or pesticides, or unintentionally because they are common metabolites in the aerobic transformation of many chlorinated pollutants. The biodegradation of 3,4-dichlorobenzoic acid compound was investigated by using Corynebacterium jeikeium bacteria, which was isolated from Petra wastewater plant in Jordan. 3,4-dichlorobenzoic acid compound (3,4-DCBA) was used as a sole carbon and energy source in minimal salt media (MSM). 3,4-DCBA was the most degradable compound among the Chlorobenzoic acid compounds tested by this bacteria. Different conditions such as substrate concentration, temperature, pH, agitation rate, carbon starvation and carbon adaptation were used to obtain optimal Biodegradation. The optimal conditions for the biodegradation were 3mM as substrate concentration and the culture conditions were also showed a significant impact on the ability of these cells to remove 3,4-DCBA. The optimum solution, temperature and agitation rate were 7.5, 37 °C and 150 rpm, respectively. Adaptation of the cells to 3,4-DCBA for 24 hr and 48 hr and cells starvation for 24 hr and 48 hr increased the initial degradation rate. The degradation ability was monitored through disappearance of the substrate from the medium and the measuring the accompanying chloride release. Corynebacterium jeikeium dioxygenases were physiologically induced by 3,4-DCBA compound. They were analyzed for both ortho or meta ring-cleavage of this aromatic compound. Only 1,2-dioxygenase activity was detected which mean that the cleavage is through the ortho pathway. This microorganism can be a valuable and promising candidate for use in the biotreatment of wastewater samples contaminated with 3,4-DCBA.
Targeted drug delivery system improves the efficiency and safety of the therapeutic agents by managing the pharmacokinetics and pharmacodynamics of drugs. Currently, numerous drug carrier systems have been developed with different sizes, architectures and characteristics surface properties. Among different systems, macromolecules have a wide range of applications in targeted drug delivery system. The optimal drug loading potential, smooth drug releasing ability and biocompatibility are the distinguishing features that ensure the drugs delivery ability of macromolecules. This review briefly introduces some of the most commonly studied macromolecules which have been recommended as drugs delivery vehicles.
Phyllidiid Nudibranchs Phyllidia varicosa and Phyllidiella pustulosa were observed under laboratory conditions and abnormal behaviours were recorded. This study described the manoeuvering, mating behaviour, egg laying and abnormal activities. Some abnormal behaviours were recorded while retaining the sample in the aquarium such as emitting noxious chemicals, lifting up the mantle edge to expose the gills and crawling towards the water surface and lie there. Maneuvering behaviour was distinguished when two individuals were interacting with each other before the mating. Mating behaviour started by extending and joining the reproductive organs followed by gamete exchange for several minutes. During the mating behaviour, there was a limited movement like contracting of the body and hiding the rhinophores into the rhino-tube. Egg deposition was observed in the aquarium as natural behavior after mating and as a stress response after placing the sample in the captivity.
Resistance to antibiotics is a significant public health issue in preventing infectious diseases. This study was designed to evaluate the antibacterial activity of eucalyptol, γ-terpinene, p-cymol and punicalagin against Methicillin (Oxacillin) resistant strains. The synergistic effect of these compounds with cefotaxime against Staphylococcus aureus was investigated. The lowest MIC value observed was 0.08mg/mL for punicalagin against S. aureus, followed by the MIC values of punicalagin against E. aerogenes, E. coli and K. pneumoniae (0.16 - 0.63mg/mL). The activity of p-cymol against S. aureus is ranked second, as indicated by the MIC value (0.63mg/mL). The results of the combination study showed that the maximum Increase in Folding Area (IFA) was reported when punicalagin was combined with cefoxitin, cefotaxime, oxacillin, and piperacillin. An effective IFA was observed when p-cymol was tested with piperacillin, cefixime, cefotaxime, oxacillin, and cefoxitin. Based on the checkerboard assay, the MIC of cefotaxime decreased from 60 to 7.5µg/mL when combined with punicalagin indicating a significant synergistic effect between cefotaxime and punicalagin against S. aureus. In conclusion, punicalagin improved S. aureus susceptibility to cefotaxime, suggesting that using these two medicines together can reverse beta-lactam resistance in methicillin (oxacillin) resistant S. aureus. Further works are required to generalize this result and then it may be useful for treating diseases caused by methicillin (oxacillin) resistant strains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.